Efectele protectoare ale remediului autohton neamon-hepa în hepatita indusă cu tetraclorură de carbon
Close
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1297 7
Ultima descărcare din IBN:
2023-08-07 18:13
SM ISO690:2012
PARII, Boris, TODIRAŞ, Mihail, PARII, Sergiu, RUSNAC, Liliana, GOLOVIN, Pavel, VALICA, Vladimir. Efectele protectoare ale remediului autohton neamon-hepa în hepatita indusă cu tetraclorură de carbon . In: Curierul Medical, 2010, nr. 2(314), pp. 31-35. ISSN 1875-0666.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Curierul Medical
Numărul 2(314) / 2010 / ISSN 1875-0666

Efectele protectoare ale remediului autohton neamon-hepa în hepatita indusă cu tetraclorură de carbon

Pag. 31-35

Parii Boris, Todiraş Mihail, Parii Sergiu, Rusnac Liliana, Golovin Pavel, Valica Vladimir
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
 
Disponibil în IBN: 7 decembrie 2013


Rezumat

The Protective Effects of Local Drug Neamon-Hepa on Carbon Tetrachloride-Induced Liver Injury The aim of this study was to assess the hepatoprotective activity of a new drug Neamon-Hepa in carbon tetrachloride (CCl4) induced chronic liver damage for 3 weeks. The Neamon-Hepa treatment produced a normalizing effect on body weight and liver/body-weight ratio, significantly lowering alanine and aspartate aminotransferase, alkaline phosphatase, total bilirubin, lactatdehidrogenase activity and serum cholesterol level. These findings suggest that Neamon-Hepa exhibits potent hepatoprotective effects in mice treated with CCl

Гепатозащитное действие препарата Neamon-Hepa при гепатите индуцированным четыреххлористным углеродом Целью данного исследования являлось изучение гепатозащитного действия нового препарата Neamon-Hepa при гепатите индуцированным четыреххлористным углеродом (CCl4) в течении 3-х недель. Лечение препаратом Neamon-Hepa привело к нормализации массы тела и нормализации индекса массы печень/тело, определило значительное понижение аланин и аспартат аминотрансфераз, алкалинфосфатазы, общего билирубина, активности лактатдегидрогеназы и уровня холестерола в плазме. Эти показатели указывают на выраженное гепатозащитное действие препарата Neamon-Hepa на мышей после воздействия CCl

Cuvinte-cheie
liver diseases, chronic hepatitis, Neamon-Hepa,

hepatoprotective remedies, CCl

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-5427</cfResPublId>
<cfResPublDate>2010-03-01</cfResPublDate>
<cfVol>314</cfVol>
<cfIssue>2</cfIssue>
<cfStartPage>31</cfStartPage>
<cfISSN>1875-0666</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/5427</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Efectele protectoare ale remediului autohton neamon-hepa în hepatita indusă cu tetraclorură de carbon
</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>liver diseases; chronic hepatitis; Neamon-Hepa; hepatoprotective remedies; CCl</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'>The Protective Effects of Local Drug Neamon-Hepa on Carbon Tetrachloride-Induced Liver Injury
The aim of this study was to assess the hepatoprotective activity of a new drug Neamon-Hepa in carbon tetrachloride (CCl4) induced chronic
liver damage for 3 weeks. The Neamon-Hepa treatment produced a normalizing effect on body weight and liver/body-weight ratio, significantly
lowering alanine and aspartate aminotransferase, alkaline phosphatase, total bilirubin, lactatdehidrogenase activity and serum cholesterol level.
These findings suggest that Neamon-Hepa exhibits potent hepatoprotective effects in mice treated with CCl
</cfAbstr>
<cfAbstr cfLangCode='RU' cfTrans='o'>Гепатозащитное действие препарата Neamon-Hepa при гепатите индуцированным четыреххлористным углеродом
Целью данного исследования являлось изучение гепатозащитного действия нового препарата Neamon-Hepa при гепатите
индуцированным четыреххлористным углеродом (CCl4) в течении 3-х недель. Лечение препаратом Neamon-Hepa привело к
нормализации массы тела и нормализации индекса массы печень/тело, определило значительное понижение аланин и аспартат
аминотрансфераз, алкалинфосфатазы, общего билирубина, активности лактатдегидрогеназы и уровня холестерола в плазме. Эти
показатели указывают на выраженное гепатозащитное действие препарата Neamon-Hepa на мышей после воздействия CCl
</cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-11767</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13498</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11462</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12016</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13503</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11802</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-11767</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11767-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
<cfFamilyNames>Parii</cfFamilyNames>
<cfFirstNames>Boris</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13498</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13498-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
<cfFamilyNames>Todiraş</cfFamilyNames>
<cfFirstNames>Mihail</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11462</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11462-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
<cfFamilyNames>Parii</cfFamilyNames>
<cfFirstNames>Sergiu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12016</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12016-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
<cfFamilyNames>Rusnac</cfFamilyNames>
<cfFirstNames>Liliana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13503</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13503-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
<cfFamilyNames>Golovin</cfFamilyNames>
<cfFirstNames>Pavel</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11802</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11802-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-03-01T24:00:00</cfStartDate>
<cfFamilyNames>Valica</cfFamilyNames>
<cfFirstNames>Vladimir</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>